Displaying results 1 - 2 of 2
Clear search
4basebio receives MHRA GMP licence for manufacture and supply of synthetic DNA
Cambridge, UK, 02 April 2025 – 4basebio PLC, a company which develops and commercialises the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, announces that it has received Good Manufacturing Practice (GMP) certification from the UK’s Medicines
4basebio appoints Gabe Longoria as Chief Commercial Officer
Cambridge, UK, 09 January 2025 - 4basebio PLC (AIM: 4BB) (“4basebio”), a company which develops and commercialises the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, today announced the appointment of Gabe Long